Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.
Thor Industries (THO - Get Report) : In an exclusive "Executive Decision" segment, Cramer spoke with Bob Martin, president and CEO of Thor Industries, the RV maker that just posted a monster 24-cents-a-share earnings beat on a 22% rise in revenue year over year. Shares of Thor rose 3.5% on the news and are up 6.7% for the month of September.
Martin said Thor dealers are excited about the company's new models, many of which cater to younger customers who crave new technology and features that make camping and getting away easier than ever.
When asked about those younger customers, Martin said Millennials are using trailers and RVs in new ways, taking lots of shorter trips to concerts. sporting events and even their kids' soccer games.
It's getting tougher to fly these days, Martin added, and with so much to see right here in the U.S. and Canada, more and more people are discovering the convenience of packing up their RV and hitting the road to get away.
Cramer said Thor is a company that continues to do everything right.
e.l.f. Beauty (ELF - Get Report) : In his "Know Your IPO" segment, Cramer looked into e.l.f. Beauty, which came public last week at $17 a share and rocketed higher by 55%. Elf, short for eyes, lips and face, is a low-cost cosmetics maker with the goal of making cosmetics accessible and affordable for all.
Cramer said there's a lot to like with elf, which began life as an online retailer and is still sports an online bias. The company has strong brand loyalty and a strong social media presence, and has only just scratched the surface of selling its wares in traditional retail channels. The company also saw 21% revenue growth in its most recent quarter. Elf is also experimenting with 12 of its own branded locations.
But on the flip side, elf is also a private equity-backed company, with two investors still owning 62% of the common stock. These investors are likely to divest their stakes via secondary offerings, diluting current ones.
Bristol-Myers Squibb (BMY - Get Report) : In the "Off the Charts" segment, Cramer checked in with colleague Tim Collins over the chart of Bristol-Myers Squibb, an Action Alerts PLUS stock that was down big in August after announcing disappointing clinical trial data.
A daily chart of Bristol clearly showed the stock's huge gap lower in early August, falling below the key 50-day moving average. Every time buyers attempted to stage a rally, Collins notes they were overwhelmed with sellers. Since then, however, the stock has held the $55 level, building a floor of support at that level.
With both the stochastics and MACD momentum indicator trending higher, Collins felt the stock could be poised to break through the ceiling of resistance sooner as opposed to later.
A peak at the weekly chart of Bristol confirmed Collins' thesis. The stock displayed a bullish hook pattern. Below $55, however, Collins would be a seller.
Cramer, on the other hand, took a longer-term view, saying he likes Bristol-Myers even more as it trends lower and its yield increases.
To read a full recap of "Mad Money" on CNBC, click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.